secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001493152-24-008824
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MyMD Pharmaceuticals regains Nasdaq minimum bid price compliance after reverse stock split
--------------------------------------------------------------------------------

- Received notice from Nasdaq on March 4, 2024 that it has regained compliance with Listing Rule 5550(a)(2).
- Deficiency flagged Oct 11, 2023 after shares failed to maintain $1.00 bid for 30 consecutive days.
- Conducted a 1-for-30 reverse stock split on Feb 14, 2024; split-adjusted trading began Feb 15.
- Minimum bid price of $1.00 maintained for 10 consecutive business days, requirement met on March 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224008824/0001493152-24-008824-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224008824/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-008824

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer